Inexpensive multi-patient respiratory monitoring system for helmet ventilation during COVID-19 pandemic ======================================================================================================= * The Princeton Open Ventilation Monitor Collaboration * Philippe Bourrianne * Stanley Chidzik * Daniel Cohen * Peter Elmer * Thomas Hallowell * Todd J. Kilbaugh * David Lange * Andrew M. Leifer * Daniel R. Marlow * Peter D. Meyers * Edna Normand * Janine Nunes * Myungchul Oh * Lyman Page * Talmo Periera * Jim Pivarski * Henry Schreiner * Howard A. Stone * David W. Tank * Stephan Thiberge * Christopher Tully ## Abstract Helmet non-invasive ventilation (NIV) is a form of continuous positive applied pressure that has emerged as a useful therapy for COVID-19 patients who require respiratory support but may not require invasive ventilation. Helmet NIV has seen an increase in use during the COVID-19 pandemic because it is low-cost, readily available, and provides viral filters between the patient and clinician. Helmet NIV may also provide better patient outcomes by delaying or eliminating the need for invasive ventilation. Its widespread adoption has been limited, however, by the lack of a respiratory monitoring system that is needed to address known safety vulnerabilities and to provide clinicians with a respiratory profile of the patient. To address this safety need, we have developed an inexpensive respiratory monitoring system that is based on readily available commercial components and is suitable for rapid local manufacture. The system is designed for use in conjunction with the COVID-19 Helmet developed by Sea-Long Medical Systems [1], but is modular and can be used with other ventilation systems. The monitoring system comprises one or more flow and pressure sensors and a central remote station that can be used to remotely monitor up to 20 patients simultaneously. The system reports flow, pressure, and clinically relevant metrics including respiratory rate, tidal volume equivalent, peak inspiratory pressure (PIP), positive end-expiratory pressure (PEEP) and the ratio of inspiratory time to expiratory time (I:E). The device will sound alarms based on clinician-set thresholds. In bench tests using a commercial ventilator and artificial lung system, our device performs comparably to a commercial single-patient respiratory monitor. Results are presented from human-subject tests on a healthy volunteer undergoing helmet non-invasive ventilation. Detailed design and manufacturing documents are provided. Keywords * COVID-19 * non-invasive ventilation * CPAP * helmet * respiratory profile monitor * remote monitoring * critical care * low-cost ventilator * emergency ventilator ## 1 Introduction Non-invasive ventilation systems, such as continuous positive application of pressure (CPAP) and high flow nasal canula, have emerged as important tools for treating coronavirus disease 2019 (COVID-19) patients who need respiratory support but not intubation [2, 3]. Such non-invasive approaches conserve traditional ventilators and improve patient outcomes by reducing or eliminating the need for invasive ventilation [4]. Additionally, COVID-19 patients show surprisingly poor outcomes on invasive ventilation [5], making non-invasive ventilation (where applicable) uniquely valuable during the pandemic. Helmet non-invasive ventilation (NIV) is a form of CPAP that uses a clear, polyvinyl chloride (PVC), bubble-like helmet, attached to a soft collar that seals around a patient’s neck [6]. The helmet delivers an air-oxygen mixture to the patient at slightly higher than atmospheric pressure, to keep the patient’s airways open and the patient oxygenated. Helmet NIV is appealing for pandemic use because it can be run directly from a constant flow of air-oxygen, which is readily available in hospitals [7]. Helmets cost less than 300 USD, are straightforward to manufacture, and have been available during the pandemic, despite supply chain disruptions for other ventilators [1]. Importantly, Helmet NIV is an enclosed system that uses viral filters to protect clinicians and other patients from droplets or aerosolized SARS-CoV-2 viral particles shed by the patient [8]. Helmet NIV is permitted by the FDA for COVID-19 treatment [9]. Despite these advantages, lingering safety concerns have prevented wider adoption of the helmet in the United States. Steady airflow is required to clear the patient’s expired CO2 from accumulating in the helmet [10]. An unexpected drop of airflow caused by a disruption in gas supply or blockage in the circuit could lead to rebreathing of CO2 and asphyxiation [11]. Therefore, one of the greatest concerns when using helmets is the lack of an effective monitoring and alarm system. Antisuffocation valves can help mitigate this risk, but ultimately a dedicated monitoring and alarm system is needed to employ helmet NIV safely [12]. Partly for this reason, helmets in the US have been primarily restricted to the ICU, where clinician-to-patient ratios are high enough to allow clinicians to observe patients around-the-clock. We have addressed these safety risks and clinical needs by developing an inexpensive respiratory profile monitoring system, which we call the Princeton Open Ventilator Monitor (POVM), that is based on readily available commercial components and is suitable for rapid fabrication during a pandemic. The system is designed for use in conjunction with non-invasive helmet ventilator systems, such as the COVID-19 Helmet developed by Sea-Long Medical Systems, LLC [1], but is modular and can be used in other systems. The system comprises one or more flow and pressure sensors per helmet, and crucially includes a central station that can be used to remotely monitor up to 20 patients simultaneously. The system reports to clinicians the flow and pressure in the helmet, the patient’s equivalent tidal volume (≈TV), respiratory rate (RR), ratio of inspiratory to expiratory time (I:E ratio), peak inspiratory pressure (PIP), and peak end expiratory pressure (PEEP). The system allows helmets to be deployed more broadly on the wards, since a single clinician can now monitor many patients simultaneously. The respiratory profile provided by the system allows clinicians to track disease progression and informs treatment decisions, including decisions about when to intubate. We have produced and tested 50 such devices in a matter of weeks at a marginal cost of under 300 USD. Commercial alternatives, like the Philips Respirionics NM3 monitor, offer some of the functionality of our device, but those systems are currently unavailable due in part to disruptions in the medical supply chain. In addition, the commercial alternatives are single-patient devices that cost 20 to 40 times more than our device, thus making them impractical for rapid scale-up and deployment in a pandemic setting. To facilitate local manufacture, we provide detailed parts lists, computer-aided design files, software, and instructions for assembly and testing. ## 2 Materials and methods ### 2.1 Design and construction of the device and software The Princeton Open Ventilation Monitor device consists of a flow-sensor assembly and an interface box located at the patient’s bedside, as well as a multi-patient remote monitoring station, as shown in Fig 1. When used with a helmet for monitoring patients undergoing non-invasive ventilation, the flow-sensor assembly is inserted into the exipiratory path. A schematic of the system is shown in Fig 2. ![Fig 1.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/06/30/2020.06.29.20141283/F1.medium.gif) [Fig 1.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/F1) Fig 1. Device monitors respiratory features by measuring pressure and flow of air leaving a helmet. Top: Device is shown installed in a typical circuit. (1) Inspiratory path. (2) Filter. (3) Patient in helmet. (4) Filter. (5) Expiratory path. (6) Flow-sensor assembly. (7) PEEP valve. (8) Interface box. The interface box reports basic respiratory information and announces audible and visual alarms if flow, pressure or respiratory rate cross clinician defined thresholds. Bottom: The remote monitoring station displays flow, pressure, and volume waveforms and clinically relevant quantities including equivalent tidal volume, respiratory rate, I:E ratio, PIP and PEEP from up to 20 devices. Here 16 devices in a test-circuit are being monitored simultaneously. ![Fig 2.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/06/30/2020.06.29.20141283/F2.medium.gif) [Fig 2.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/F2) Fig 2. Schematic of system design. #### 2.1.1 Differential pressure sensor The flow meter consists of a differential pressure sensor that measures the pressure drop across a flow channel. This pressure drop is then used to calculate flow through the channel. The differential pressure sensor was chosen to be capable of measuring relatively small pressure drops (±500 Pa) with good dynamic range. Stable operation in a humid environment was also a key consideration, as were cost and availability. The device selected was the Sensirion SDP31 differential pressure sensor. This part works by diverting a small portion of the flow and measuring the change in temperature as the gas passes over a small internal heating element. The temperature change in the gas as it flows through the sensor is related to the mass flow rate of the diverted flow stream, which in turn is related to the pressure difference across the sense ports. Readings from the SDP31 are routed to the controller over an I2C bus at a rate of 120 readings per second. The SDP31 flow sensor, which comes in a surface mount package, is mounted to a small printed circuit board (PCB, see Supplementary Design File 1) that is fixed to the flow block as shown in Fig. 3. To prevent condensation from forming in the narrow flow-sensor channel, a heater has been added. Heat is generated in a TIP32 transistor housed in a TO-220 package. The TIP32 is mounted on the opposite side of the printed circuit board from the SDP31. Operating the transistor at a power of less than 1 W suffices to raise the temperature in the SDP31 sensor to 45 *°*C, which is above the dew point of the air in the system. The operating temperature is regulated using a pulse-width modulation signal from the readout controller. ![Fig 3.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/06/30/2020.06.29.20141283/F3.medium.gif) [Fig 3.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/F3) Fig 3. Flow-sensor assembly. A flow and pressure sensor are exposed to the flow element. The electronic sensor elements are mounted on circuit boards that connect to an external RaspberryPi controller via a standard RJ-45 jack. #### 2.1.2 Gauge pressure sensor A second sensor, the MP3V5004G from Freescale Semicondutor, is included to measure the gauge pressure in the flow block. The MP3V5004G measures pressures in the range 0 *< p <* 3920 Pa (approximately 0 to 40 cm H2O) and provides an analog output in the range 0.6 * given the length *L* and diameter *D* of a pipe, and a Darcy friction factor *f**D* that depends on the Reynolds number. At 100 L/min our device operates at an intermediate Reynolds number of Re ≈ 1800, which is neither in the high (Re ≫ 2000) nor low (Re ≪ 2000) turbulence limits. (Re = *V D/ν*, where the kinematic viscosity of air *ν ≃* 2 × 105 m2/s. At *Q* = 100 L/min, air through one of the 19 honeycomb channels of diameter *D ≃* 3 mm travels at approximately *V*1 *≃* 12 m/s.) The relation between a Darcy friction factor *f**D* and Reynolds number can be looked up in standard Moody diagrams [15]. For turbulent flow in sufficiently long smooth tubes, *f* Re*−*1*/*4, which implies Δ*P Q*7*/*4. When our flow is lower, the Reynolds number drops. At a flow of 10 L/min (Re = *O*(200)), the flow in a shorter tube will have a growing boundary layer. In such laminar flow cases we expect Δ*P ∝ Q*3*/*2. We note that our calibration lookup table follows the Δ*P ∝ Q*7*/*4 for high flows and the Δ*P ∝ Q*3*/*2 for lower flows in agreement with expectations (Fig. 9). #### 2.2.4 Gauge pressure test The gauge pressure sensor was calibrated by imposing a constant pressure with a pressure controller (Fluigent MFCS-EZ). The sensor saturates at a value around 3000 Pa and exhibits a linear response, see Fig. 11. ![Fig 11.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/06/30/2020.06.29.20141283/F11.medium.gif) [Fig 11.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/F11) Fig 11. Pressure sensor calibration. The pressure *P* measured varies linearly (solid line of slope 0.81) with the pressure *P*app applied with the Fluigent pressure controller and saturates above 3000 Pa. #### 2.2.5 Methods for bench test comparison to commercial medical systems To compare our device against commercial systems, the April 22nd version of our device was tested on a commercial test lung (IngMar ASL5000) driven by a commercial ventilator (GE Avance CS2 Anaesthesia System) in series with a commercial respiratory monitoring system (Philips Respironics NM3). Our device and the commercial monitoring system were both situated in-line on the inspiratory path of the ventilator circuit. Simultaneous recordings of pressure and flow were made from our device, the commercial monitor, and the test lung system. Ground-truth volume information was also recorded from the test lung and precisely time-aligned. Pressure information from our device was also compared to the commercial monitor (NM3). Respiratory rate, PIP and PEEP were also recorded from our device and occasionally compared to the display of the commercial ventilator. Our device was tested under a variety of ventilation modes including Pressure Control Ventilation, Volume Control Ventilation, and Synchronized Intermittent-Mandatory Ventilation with Pressure Control (SIMV PC). The test lung’s compliance was varied from 80 mL/cm H2O, typical for a healthy adult, to 20 mL/cm H2O which is more typical of a diseased lung. Respiratory rate was set on either the ventilator or the lung to be approximately 15 breaths per minute. #### 2.2.6 Quality control and acceptance testing of final assembled devices We developed a quality control protocol that could be used to test finished assembled devices prior to delivering to patients. The test demonstrates that each flow-sensor assembly’s combination of specific flow element and sensors gives measured results for flow and pressure within a set range, for example 10±% of actual values. This was done by providing a known flow (using an Aalborg GFC47 mass flow controller) or known pressure (measured at a low flow using a water manometer sampling the flow just upstream of the flow element), recording sensor data with an interface box, analyzing the data using the fixed average calibrations discussed in Sec. 2.2.3 and 2.2.4, and comparing the recorded data to the known values. ### 2.3 Methods for human subject test Human subject tests were conducted in accordance with IRB protocol # 12857 approved by Princeton University’s Institutional Review Board. Written consent was obtained from a healthy adult volunteer. The subject was placed in a helmet (Sea Long Model PN5404) fed by 80 L/min of medical air (AirGas) configured as shown in Fig 1 with the PEEP valve set to its lowest limit, nominally 5 cmH2O. A one way valve (Teleflex Model 1644) was added to one of the helmet ports to serve as an anti-suffocation valve. The subject was in a standing position. The subject’s spontaneous breathing was recorded on our respiratory monitor device over two 20 min trials as the subject was instructed to breath normally. A water manometer in our air delivery system appeared to contribute to dynamic changes to the volume in the helmet circuit coincident with the subject’s breathing, so the manometer was inactivated during portions of the recording. ## 3 Results ### 3.1 Flow, pressure and tidal volume agree with commercial systems We placed a prototype of our device in a circuit with a commercial single-patient respiratory monitoring system (Philips NM3) on a test lung (ASL-5000) driven by a commercial ventilator. We compared recordings made by our device to those made by the test lung and the commercial monitoring system. Recordings from our device show strong agreement with the test lung for flow and volume. See Figs. 12, 13 and 14. ![Fig 12.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/06/30/2020.06.29.20141283/F12.medium.gif) [Fig 12.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/F12) Fig 12. Comparison to commercial monitor. Overlay of flow and pressure measured simultaneously from the Princeton Open Vent Monitor, a commercial respiratory monitor (NM3), and an artificial lung (ASL-5000) driven by a commercial ventilator. ![Fig 13.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/06/30/2020.06.29.20141283/F13.medium.gif) [Fig 13.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/F13) Fig 13. Volume comparison to test lung. Overlay of derived volume from the Princeton Open Vent Monitor (using the high-pass filter with the weaker 0.0004 Hz Butterworth critical frequency) and measured volume from an artificial lung (ASL-5000), driven by a commercial ventilator. ![Fig 14.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/06/30/2020.06.29.20141283/F14.medium.gif) [Fig 14.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/F14) Fig 14. Fine comparison of Princeton Open Ventilation Monitor (POVM), the artificial lung simulator (ASL), and a commercial respiratory monitor (NM3) in matched time-bins (100 ms wide). The commercial monitor occasionally drops to zero and has discretization effects at low pressure. POVM and ASL agree in flow up to a 5% scale factor; POVM and NM3 agree in flow up to a 15% scale factor, and POVM and NM3 agree in pressure up to a 5% scale factor. ![Fig 15.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/06/30/2020.06.29.20141283/F15.medium.gif) [Fig 15.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/F15) Fig 15. Respiratory profile of healthy human subject in helmet. Top: Pressure, flow and integrated flow for gas on the expiratory path of a helmet worn by a healthy human subject is shown. Positive flow is defined to be gas leaving the helmet through the expiratory path. Bottom: Derived quantities, including tidal volume, respiratory rate, etc are visible on the remote monitoring station (shown here in “drilldown” screen). Our device’s flow measurement showed closer agreement to the test lung than the commercial monitoring system that was measuring flow simultaneously. There was a scaling factor of about 5% discrepancy between our device and the test lung’s measured flow, while the commercial monitor reported flows that differed from our device by a scaling factor of about 15% and an offset of 2 L/min. The commercial respiratory monitor also would occasionally show a flat line for flow or pressure during a breath, while our system captured dynamics of all breaths (see artifact at approximately 158 s in Fig. 12 and as a horizontal spread around zero in Fig. 14). In measures of pressure, our system had close agreement to the commercial respiratory monitor. We note that our system seemed to avoid quantization artifacts found in the commercial monitoring system at low pressures (see steps in pressure around 80 s in NM3 recording in Fig. 12). We also compared derived quantities—the equivalent tidal volume, PIP, PEEP, and breathing rate—with those reported by the ventilator at the same time. Our system largely agrees with the ventilator’s own settings (see Table 5). View this table: [Table 5.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/T5) Table 5. Comparison of derived quantities. Princeton Open Vent Monitor (POVM) derived tidal volume equivalent (≈TV), peak inspiratory (PIP) and end-expiratory (PEEP) pressure, and breathing rate (RR) compared with contemporaneous readings/settings from the ventilator and readings from the commercial monitor (NM3). ### 3.2 Human volunteer study A healthy consenting adult volunteer was placed in a helmet and received medical air at 80 L/min while undergoing monitoring with our device. The device captured reasonable waveforms for flow, pressure and equivalent tidal volume, as shown in Fig. 15. The measured respiratory rate matched that reported by the subject. Measured flow waveforms appear qualitatively similar to previous reports of human subjects in a helmet [10]. Recorded device data stream is available in Supplementary Data Files 1. ### 3.3 External sources of variability We tested the influence of relative humidity on our sensors, Fig. 8(d). We challenged our device by measuring 20 hours of continuous flow of saturated humid air (*RH* = 100%). Both sensors performed even in the presence of significant condensation in the flow element, which suggests that our heater circuit functions effectively. In tests with variable humidity, we observed that the flow *Q* increased slightly by less than 3% while the humidity rose from 5 to 100%. Finally, the presence of curvature in tubing has been reported to affect measures of downstream flow [16, 17]. This is relevant because our device may dangle off the helmet at an angle, as can be seen in Fig. 1. We introduced a 90*°*bend into the tubing a variable distance *L* upstream of our device and observed the change in our device’s reported flow *Q* under a constant imposed flow of 100 L/min, Fig. 8(e) and Fig. 16. We observed a systematic increase in the flow *Q* reported by our device for bends less than 30 cm upstream of our device. The largest deviations from the imposed flow occurred when the bend was closest to the device (5% for *L* = 5 cm). ![Fig 16.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/06/30/2020.06.29.20141283/F16.medium.gif) [Fig 16.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/F16) Fig 16. Effect of bent tubing. Flow *Q* measured by our flow sensor in the presence of a 90*°*bend positioned a distance *L* upstream of the flow block. A 100 L/min flow was imposed by a Mass Flow Controller. ### 3.4 Results of production run We completed a production run of 50 devices. Producing devices at scale posed additional challenges regarding calibration and quality control. In particular manufacturing defects in the flow element altered the relationship between the measured pressure difference Δ*P* and the flow *Q* across the device, as shown in Fig. 10. Initial determination of Δ*P* vs. *Q* for each flow element with a fixed sensor array allowed us to eliminate outliers from the determination of the average calibration. After each flow element is integrated into its final flow-sensor assembly, it will undergo the acceptance testing described in Sec. 2.2.6. An example test result is shown in Fig. 17. ![Fig 17.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/06/30/2020.06.29.20141283/F17.medium.gif) [Fig 17.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/F17) Fig 17. Results of acceptance testing of a final flow-sensor assembly. Left: comparison of calibrated flow reported by the device under a test to flow set by a Mass Flow Controller. Right: comparison of calibrated pressure reported by the device under test to pressure measured with a water manometer. Red text uniquely identifies the flow-sensor assembly. ## 4 Discussion and Conclusion We designed and built an inexpensive respiratory monitoring device from conception to production in a six week period coincident with the initial peak of the COVID-19 pandemic in our region. Our device shows similar, and in some aspects better, agreement with a test lung than a commercial monitoring system that is currently unavailable. Measurements of a healthy volunteer in a helmet taken by our device are reasonable and match prior reports. Our device has the potential to improve patient outcomes and to mitigate well-documented safety concerns regarding CO2 re-breathing that have prevented the helmet’s widespread adoption. Our device also introduces the ability to monitor many patients simultaneously. Importantly, our device uses off-the-shelf components that have shown themselves to be robust to supply chain disruptions. The device is well suited for local manufacture during a pandemic. The device is designed for helmet systems but we have also successfully tested it in traditional invasive ventilator settings. We currently are seeking FDA emergency use authorization. For future versions of the device we are exploring adding CO2- and O2-sensors, and possibly adding hardware, such as an EEPROM, with each sensor board to enable per-sensor calibration curves. ## Data Availability Relevant human subject data is included as supplementary material. All design files are included as supplementary material. Links to software repositories are included in the manuscript. ## 6 Supporting information **Supplementary Video 1. Instructional video showing interface box assembly**. Video available online at [https://vimeo.com/433023739](https://vimeo.com/433023739). **Supplementary Design File 1. Compressed design files**. A zip file, SuppDesignFiles.zip (1.8 MB), containing computer aided design files for laser cutting, 3D printing and CNC machining the interface box enclosure, flow-sensor assembly cap and flow element. Contents are described in Table S1. **Supplementary Design File 2. Detailed Bill of Materials**. Spreadsheet in excel format, BillOfMaterials.xlsx (17 kB), containing detailed pricing and parts numbers for all components. **Supplementary Data Files 1. Human subject recording**. hum_subj.zip (3.6 MB) Recording of a healthy human subject volunteer breathing normally in a helmet for approximately two 20 min sessions. A portion of this recording is shown in Fig. 15. The compressed zip file containing two files within it: the first, device output.json, is a data stream recorded from the Princeton Open Ventilator Monitor in JSON format that includes raw sensor readings. The second, hum\_subj\_waveforms.csv, is a corresponding CSV file that contains recorded pressure, flow and volume over time in real-world units. The CSV file contains two volumes corresponding to the more- or less-aggressively high-passed filtered volumes discussed in the text. Note the volumes have undefined offsets. View this table: [Table S1.](http://medrxiv.org/content/early/2020/06/30/2020.06.29.20141283/T6) Table S1. Contents of Supplementary Design File 1: SuppDesignFiles.zip. ## 5 Acknowledgements This project is supported by Princeton University, including generous support by the Provost’s Office, and by National Science Foundation grants OAC-1836650, PHY-2031509 and IOS-1845137. Any opinions, findings, conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or Princeton University. We acknowledge contributions from all members of the Princeton Open Ventilation Monitor Collaboration, including Lauren Callahan, Matthew Creamer, Sophie Dvali, Alexander E. Gaillard, Alex Glaser, Bert G. Harrop, Darryl Johnson, Julienne M. LaChance, Theodore H. Lewis III, Martina Macakova, Mala Murthy, Jonathan Prevost, P. Dylan Rich, William R. Sands and Lisa Scalice. We would like to thank Dr. Ronah Harris for shooting and editing the supplementary video. We are grateful for productive conversations with Dr. Jacob Brenner, Dr. James Weimer, Dr. Maurizio Cereda, Dr. Barry Fuchs, Mike Frazer and Victoria Berehnolz all of Penn Health Tech. We thank Sebastian Seung and his volunteers for feedback. We thank Theodor Brasoveanu and his students at the Princeton Day School for supplies. We thank Meghan Testerman of Princeton University Libraries for assistance. ## Footnotes * ¶ Membership list can be found in the Acknowledgements section. * Received June 29, 2020. * Revision received June 29, 2020. * Accepted June 30, 2020. * © 2020, Posted by Cold Spring Harbor Laboratory This pre-print is available under a Creative Commons License (Attribution-NoDerivs 4.0 International), CC BY-ND 4.0, as described at [http://creativecommons.org/licenses/by-nd/4.0/](http://creativecommons.org/licenses/by-nd/4.0/) ## References 1. 1.Sea-Long Medical Systems website;. [https://www.sea-long.com/](https://www.sea-long.com/). 2. 2.Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020;doi:10.1001/jama.2020.4031. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.2020.4031&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32167538&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F30%2F2020.06.29.20141283.atom) 3. 3.Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, et al. Intensive Care Management of Coronavirus Disease 2019 (COVID-19): Challenges and Recommendations. The Lancet Respiratory Medicine. 2020;8(5):506–517. doi:10.1016/S2213-2600(20)30161-2. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S2213-2600(20)30161-2&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32272080&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F30%2F2020.06.29.20141283.atom) 4. 4.Patel BK, Wolfe KS, Pohlman AS, Hall JB, Kress JP. Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA. 2016;315(22):2435–2441. doi:10.1001/jama.2016.6338. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.2016.6338&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=27179847&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F30%2F2020.06.29.20141283.atom) 5. 5.Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;doi:10.1001/jama.2020.6775. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.2020.6775&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32320003&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F30%2F2020.06.29.20141283.atom) 6. 6.Antonelli M, Conti G, Pelosi P, Gregoretti C, Pennisi MA, Costa R, et al. New Treatment of Acute Hypoxemic Respiratory Failure: Noninvasive Pressure Support Ventilation Delivered by Helmet–a Pilot Controlled Trial. Critical Care Medicine. 2002;30(3):602–608. doi:10.1097/00003246-200203000-00019. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/00003246-200203000-00019&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=11990923&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F30%2F2020.06.29.20141283.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000174446300019&link_type=ISI) 7. 7.Savickaite A. Video: Non-Invasive CPAP by Helmet Setup COVID-19, Maurizio Franco Cereda, MD; 2020. [https://www.helmetbasedventilation.com/post/video-non-invasive-cpap-by-helmet-setup-covid-19-maurizio-franco-cereda-md](https://www.helmetbasedventilation.com/post/video-non-invasive-cpap-by-helmet-setup-covid-19-maurizio-franco-cereda-md). 8. 8.Cabrini L, Landoni G, Zangrillo A. Minimise Nosocomial Spread of 2019-nCoV When Treating Acute Respiratory Failure. The Lancet. 2020;395(10225):685. doi:10.1016/S0140-6736(20)30359-7. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(20)30359-7&link_type=DOI) 9. 9.U S Food and Drug Administration. Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency; Sun, 03/22/2020 - 12:57. [https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-ventilators-and-accessories-and-other-respiratory-devices-during-coronavirus](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-ventilators-and-accessories-and-other-respiratory-devices-during-coronavirus). 10. 10.Taccone P, Hess D, Caironi P, Bigatello LM. Continuous Positive Airway Pressure Delivered with a “Helmet”: Effects on Carbon Dioxide Rebreathing. Critical Care Medicine. 2004;32(10):2090–2096. doi:10.1097/01.ccm.0000142577.63316.c0. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/01.CCM.0000142577.63316.C0&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15483419&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F30%2F2020.06.29.20141283.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000224692800016&link_type=ISI) 11. 11.Patroniti N, Saini M, Zanella A, Isgrò S, Pesenti A. Danger of Helmet Continuous Positive Airway Pressure during Failure of Fresh Gas Source Supply. Intensive Care Medicine. 2007;33(1):153–157. doi:10.1007/s00134-006-0446-5. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s00134-006-0446-5&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17115133&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F30%2F2020.06.29.20141283.atom) [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000243464300025&link_type=ISI) 12. 12.Milan M, Zanella A, Isgrò S, Deab SAEAES, Magni F, Pesenti A, et al. Performance of Different Continuous Positive Airway Pressure Helmets Equipped with Safety Valves during Failure of Fresh Gas Supply. Intensive Care Medicine. 2011;37(6):1031–1035. doi:10.1007/s00134-011-2207-3. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s00134-011-2207-3&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21448714&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F06%2F30%2F2020.06.29.20141283.atom) 13. 13.Cryogenic Institute of New England, Inc.;. 14. 14.Riverbank Computing. PyQt5; 2018. Available from: [https://riverbankcomputing.com/software/pyqt/intro](https://riverbankcomputing.com/software/pyqt/intro). 15. 15.Moody F. Friction factors for pipe flow;. 16. 16.Dean WR. LXXII. The stream-line motion of fluid in a curved pipe (Second paper). The London, Edinburgh, and Dublin Philosophical Magazine and Journal of Science. 1928;5(30):673–695. doi:10.1080/14786440408564513. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/14786440408564513&link_type=DOI) 17. 17.Hellström LHO, Zlatinov MB, Cao G, Smits AJ. Turbulent pipe flow downstream of a 90° bend. Journal of Fluid Mechanics. 2013;735:R7. doi:10.1017/jfm.2013.534. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1017/jfm.2013.534&link_type=DOI) [1]: /embed/graphic-15.gif